Increased poly(ADP-ribosyl)ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment.
about
Burns: an update on current pharmacotherapyTime-Dependent and Organ-Specific Changes in Mitochondrial Function, Mitochondrial DNA Integrity, Oxidative Stress and Mononuclear Cell Infiltration in a Mouse Model of Burn InjuryRegulation of mitochondrial poly(ADP-Ribose) polymerase activation by the β-adrenoceptor/cAMP/protein kinase A axis during oxidative stress.Skeletal Muscle Loss is Associated with TNF Mediated Insufficient Skeletal Myogenic Activation After BurnThe roles of beta-adrenergic receptors in tumorigenesis and the possible use of beta-adrenergic blockers for cancer treatment: possible genetic and cell-signaling mechanismsTherapeutic applications of PARP inhibitors: anticancer therapy and beyondThe surgically induced stress response.The role of Beta-adrenergic receptor blockers in Alzheimer's disease: potential genetic and cellular signaling mechanisms.The role of β-adrenergic blockers in Parkinson's disease: possible genetic and cell-signaling mechanisms.The clinically used poly(ADP-ribose) polymerase (PARP) inhibitor olaparib improves organ function, suppresses inflammatory responses and accelerates wound healing in a murine model of third-degree burn injury.Alcohol Modulation of the Postburn Hepatic Response.
P2860
Q24618730-7ACD9827-942B-4031-807C-F622321FD50DQ28551267-B4125619-C708-42EB-8D93-02D759ABFB1AQ34186029-4C878532-DBAF-42C8-8054-07E01F00DCE6Q36190823-5CE5AB83-F687-434F-9BBD-51AEE8BF7C57Q36500327-14FE60A0-B5FD-49A8-8BC9-CAE9C8AC14B9Q36853236-C8902284-391E-45E5-9C83-466D97F5D577Q37577359-7F647FCC-E62D-4A8D-B28D-B44CEE52CAECQ38108100-1B0FF408-CC11-4379-B7AB-DA4071539200Q38108496-F454FBE3-E1F0-4454-920E-1FA4F7F9FF09Q38986446-D51BA282-47AD-4489-96F3-B74076CD6081Q53967982-EBE533D3-C4C6-437E-8CE0-F9FDAA78C63C
P2860
Increased poly(ADP-ribosyl)ation in skeletal muscle tissue of pediatric patients with severe burn injury: prevention by propranolol treatment.
description
2011 nî lūn-bûn
@nan
2011 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@ast
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@en
type
label
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@ast
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@en
prefLabel
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@ast
Increased poly(ADP-ribosyl)ati ...... tion by propranolol treatment.
@en
P2093
P2860
P1433
P1476
Increased poly(ADP-ribosyl)ati ...... ntion by propranolol treatment
@en
P2093
Celeste C Finnerty
Csaba Szabó
David N Herndon
Elena Sbrana
Gábor Oláh
Itoro Elijah
P2860
P356
10.1097/SHK.0B013E3182168D8F
P50
P577
2011-07-01T00:00:00Z